Collider bias undermines our understanding of COVID-19 disease risk and severity
University of Bristol · Medical Research Council · +2 more institutions
Abstract
Numerous observational studies have attempted to identify risk factors for infection with SARS-CoV-2 and COVID-19 disease outcomes. Studies have used datasets sampled from patients admitted to hospital, people tested for active infection, or people who volunteered to participate. Here, we highlight the challenge of interpreting observational evidence from such non-representative samples. Collider bias can induce associations between two or more variables which affect the likelihood of an individual being sampled, distorting associations between these variables in the sample. Analysing UK Biobank data, compared to the wider cohort the participants tested for COVID-19 were highly selected for a range of genetic,…
Citation impact
- FWCI
- 17.55
- Percentile
- 100%
- References
- 103
Authors
14- GJGareth J GriffithCorresponding
University of Bristol, Medical Research Council
- TMTim Morris
University of Bristol, Medical Research Council
- MTMatthew Tudball
University of Bristol, Medical Research Council
- AHAnnie Herbert
University of Bristol, Medical Research Council
- GMGiulia Mancano
University of Bristol, Medical Research Council
Topics & keywords
- Collider
- Observational study
- Biobank
- Coronavirus disease 2019 (COVID-19)
- Disease
- Medicine
- Causal inference
- Sample size determination
- Good health and well-being
Funding
- WWellcomeAward: 208806/Z/17/Z
- WTWellcome TrustAwards: Z/17/Z, 208806/Z/17/Z
- UOUniversity of BristolAwards: MC_UU_00011/1, ES/T009101/1, MC_UU_00011/3
- NFNorges ForskningsrådAward: 295989
- MRMedical Research CouncilAwards: MR/S002634/1, MC_UU_00011/3, MC_PC_17228, MC_UU_00011/1, MC_UU_00011/3, MC_UU_00011/1, MC_UU_00011, MR/S002634/1, MC_UU_00011/1, MC_UU_00011/3
- EAEconomic and Social Research CouncilAwards: ES/T009101/1, ES/T009101/1